NO20091495L - Pyrazolopyrimidinderivat - Google Patents

Pyrazolopyrimidinderivat

Info

Publication number
NO20091495L
NO20091495L NO20091495A NO20091495A NO20091495L NO 20091495 L NO20091495 L NO 20091495L NO 20091495 A NO20091495 A NO 20091495A NO 20091495 A NO20091495 A NO 20091495A NO 20091495 L NO20091495 L NO 20091495L
Authority
NO
Norway
Prior art keywords
formula
compound represented
hsp90
compound
antitumor activity
Prior art date
Application number
NO20091495A
Other languages
English (en)
Norwegian (no)
Inventor
Satoru Ohsuki
Atsushi Tengeiji
Masahiro Ikeda
Yoshihiro Shibata
Chikahiro Nagata
Takashi Shimada
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of NO20091495L publication Critical patent/NO20091495L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/16Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20091495A 2006-09-19 2009-04-16 Pyrazolopyrimidinderivat NO20091495L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006253465 2006-09-19
PCT/JP2007/067933 WO2008035629A1 (fr) 2006-09-19 2007-09-14 Dérivé de pyrazolopyrimidine

Publications (1)

Publication Number Publication Date
NO20091495L true NO20091495L (no) 2009-06-18

Family

ID=39200455

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091495A NO20091495L (no) 2006-09-19 2009-04-16 Pyrazolopyrimidinderivat

Country Status (26)

Country Link
US (1) US8158638B2 (es)
EP (1) EP2065388B1 (es)
JP (1) JP5252636B2 (es)
KR (2) KR20140127367A (es)
CN (1) CN101541811B (es)
AT (1) ATE523513T1 (es)
AU (1) AU2007298286B2 (es)
BR (1) BRPI0717176A2 (es)
CA (1) CA2663965C (es)
CO (1) CO6210702A2 (es)
CY (1) CY1112191T1 (es)
DK (1) DK2065388T3 (es)
ES (1) ES2373160T3 (es)
HK (1) HK1127476A1 (es)
IL (1) IL197513A (es)
MX (1) MX2009002998A (es)
MY (1) MY145041A (es)
NO (1) NO20091495L (es)
NZ (1) NZ575564A (es)
PL (1) PL2065388T3 (es)
PT (1) PT2065388E (es)
RU (1) RU2420530C2 (es)
SI (1) SI2065388T1 (es)
TW (1) TWI388563B (es)
WO (1) WO2008035629A1 (es)
ZA (1) ZA200901921B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ595233A (en) * 2009-02-25 2013-01-25 Daiichi Sankyo Co Ltd Tricyclic pyrazolopyrimidine derivatives
AU2010232647A1 (en) * 2009-03-31 2011-10-20 Arqule, Inc. Peri-fused pyrazolo-pyrimidine compounds
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
TW201213333A (en) 2010-08-23 2012-04-01 Daiichi Sankyo Co Ltd Crystal forms of tricyclic pyrazolopyrimidine derivative
WO2012026433A1 (ja) 2010-08-23 2012-03-01 第一三共株式会社 三環性ピラゾロピリミジン誘導体のフリー体結晶
EP3024457A4 (en) 2013-07-26 2017-06-28 Update Pharma Inc. Compositions to improve the therapeutic benefit of bisantrene
CN114380738A (zh) * 2021-09-28 2022-04-22 都创(重庆)医药科技有限公司 一种3-溴-4-氯-2-甲基吡啶的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9615934D0 (en) 1996-07-30 1996-09-11 Netlon Ltd Integral tube
US6600028B1 (en) * 1997-04-02 2003-07-29 Amersham Pharmacia Biotech Uk Limited Tricyclic base analogues
EP0973788A1 (en) 1997-04-02 2000-01-26 Amersham Pharmacia Biotech UK Limited Tricyclic base analogues
BR0315688A (pt) 2002-11-22 2005-09-06 Japan Tobacco Inc Compostos, composições farmacêuticas e seus usos no tratamento ou prevenção de doenças ou condições de proliferação celular metabólicas
EP1660511B1 (en) * 2003-08-27 2010-11-03 Biota Scientific Management Pty. Ltd. Novel tricyclic nucleosides or nucleotides as therapeutic agents
WO2005028434A2 (en) * 2003-09-18 2005-03-31 Conforma Therapeutics Corporation Novel heterocyclic compounds as hsp90-inhibitors
TW200612918A (en) 2004-07-29 2006-05-01 Threshold Pharmaceuticals Inc Lonidamine analogs

Also Published As

Publication number Publication date
AU2007298286A1 (en) 2008-03-27
CA2663965C (en) 2012-06-12
IL197513A (en) 2014-01-30
TWI388563B (zh) 2013-03-11
RU2009114731A (ru) 2010-10-27
KR101485199B1 (ko) 2015-01-22
EP2065388B1 (en) 2011-09-07
US20100113410A1 (en) 2010-05-06
ZA200901921B (en) 2009-12-30
KR20140127367A (ko) 2014-11-03
IL197513A0 (en) 2009-12-24
PL2065388T3 (pl) 2012-02-29
PT2065388E (pt) 2011-11-10
BRPI0717176A2 (pt) 2013-10-15
ATE523513T1 (de) 2011-09-15
MY145041A (en) 2011-12-15
KR20090066274A (ko) 2009-06-23
CO6210702A2 (es) 2010-10-20
CY1112191T1 (el) 2015-12-09
CA2663965A1 (en) 2008-03-27
EP2065388A1 (en) 2009-06-03
WO2008035629A1 (fr) 2008-03-27
NZ575564A (en) 2011-02-25
EP2065388A4 (en) 2009-11-18
AU2007298286B2 (en) 2011-02-03
ES2373160T3 (es) 2012-02-01
CN101541811B (zh) 2014-07-09
DK2065388T3 (da) 2012-01-09
RU2420530C2 (ru) 2011-06-10
JP5252636B2 (ja) 2013-07-31
HK1127476A1 (en) 2009-09-25
CN101541811A (zh) 2009-09-23
TW200823223A (en) 2008-06-01
MX2009002998A (es) 2009-04-02
SI2065388T1 (sl) 2012-03-30
US8158638B2 (en) 2012-04-17
JPWO2008035629A1 (ja) 2010-01-28

Similar Documents

Publication Publication Date Title
CY1112191T1 (el) Παραγωγο πυραζολοπυριμιδινης
DK1853602T3 (da) Kemiske forbindelser
DK1853588T3 (da) Kemiske forbindelser
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
MX2007002398A (es) Nuevas composiciones farmaceuticas para el tratamiento de cancer.
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
DE602006013191D1 (de) Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren
BRPI0714885B8 (pt) compostos terapêuticos e seu uso
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
ATE543803T1 (de) 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren
EA201170344A1 (ru) Азаиндольные ингибиторы iap
MXPA05010020A (es) Derivados de oxamida.
MX2011008677A (es) Derivados de pirazolopirimidina triciclicos.
MX2009005912A (es) Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos.
IL191670A0 (en) Compounds for the inhibition of apoptosis
MX2007013305A (es) Nuevas tiazolidinonas sin nitrogeno basico, su produccion y su uso como agentes farmaceuticos.
ATE540920T1 (de) Aminobenzocycloheptenderivate, verfahren zu deren herstellung und deren verwendung in der therapie
ATE509956T1 (de) Spezifische proteaseinhibitoren und ihre verwendung in der krebstherapie
TNSN07283A1 (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
GB2452142A (en) Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
TH159358A (th) สารยับยั้งไพริดิลของการส่งสัญญาณเฮดจ์ฮ็อก
UA93197C2 (ru) Производные пиразолиламинопиридина, способ их получения, их применения и фармацевтическая композиция (варианты)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application